Clinical Trial Update: Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study [Phase 1]

View source ↗

Summary

A Phase I trial evaluating autologous mesenchymal stem cell transplantation for spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous Mesenchymal Stem Cells Transplantation

Snippet

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Conditions: Spinal Cord Injury | Phase 1 | Status: COMPLETED